TRP channels in cell survival and cell death in normal and transformed cells

Cell Calcium

Volumn 50, Issue 3, 2011, Pages 295-302

  Shapovalov, George ^a   Lehen'kyi, V'yacheslav ^a   Skryma, Roman ^a   Prevarskaya, Natalia ^a  

^a Université des Sciences et Technologies de Lille   (France)

Author keywords

Apoptosis; Cancer; Cell death; Ion channel; Proliferation; Survival; TRP

Indexed keywords

CALCIUM ION; TRANSCRIPTION FACTOR NFAT; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 4; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; TRANSIENT RECEPTOR POTENTIAL CHANNEL M5; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 6;

APOPTOSIS; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DEATH; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; REVIEW; SECOND MESSENGER;

EID: 80052338518     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.05.006     Document Type: Review

References (108)

1. Costa-Pereira A.P., Cotter T.G. Molecular and cellular biology of prostate cancer - the role of apoptosis as a target for therapy. Prostate Cancer and Prostatic Diseases 1999, 2:126-139.
2. Tapia-Vieyra J.V., Mas-Oliva J. Apoptosis and cell death channels in prostate cancer. Archives of Medical Research 2001, 32:175-185.
3. Wertz I.E., Dixit V.M. Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells. The Journal of Biological Chemistry 2000, 275:11470-11477.
4. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007, 445:656-660.
5. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
6. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nature Reviews. Molecular Cell Biology 2003, 4:552-565.
7. Pinton P., Giorgi C., Siviero R., Zecchini E., Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 2008, 27:6407-6418.
8. Prevarskaya N., Skryma R., Shuba Y. Ca2+ homeostasis in apoptotic resistance of prostate cancer cells. Biochemical and Biophysical Research Communications 2004, 322:1326-1335.
9. Vanden Abeele F., Skryma R., Shuba Y., Van Coppenolle F., Slomianny C., Roudbaraki M., Mauroy B., Wuytack F., Prevarskaya N. Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 2002, 1:169-179.
10. Vanoverberghe K., Vanden Abeele F., Mariot P., Lepage G., Roudbaraki M., Bonnal J.L., Mauroy B., Shuba Y., Skryma R., Prevarskaya N. Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells. Cell Death and Differentiation 2004, 11:321-330.
11. Owsianik G., D'Hoedt D., Voets T., Nilius B. Structure-function relationship of the TRP channel superfamily. Reviews of Physiology, Biochemistry and Pharmacology 2006, 156:61-90.
12. Nilius B., Owsianik G., Voets T., Peters J.A. Transient receptor potential cation channels in disease. Physiological Reviews 2007, 87:165-217.
13. Roderick H.L., Cook S.J. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nature Reviews. Cancer 2008, 8:361-375.
14. Cook S.J., Lockyer P.J. Recent advances in Ca(2+)-dependent Ras regulation and cell proliferation. Cell Calcium 2006, 39:101-112.
15. Whitfield J.F. Calcium signals and cancer. Critical Reviews in Oncogenesis 1992, 3:55-90.
16. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nature Reviews. Molecular Cell Biology 2003, 4:517-529.
17. Rizzuto R., Pinton P., Ferrari D., Chami M., Szabadkai G., Magalhaes P.J., Di Virgilio F., Pozzan T. Calcium and apoptosis: facts and hypotheses. Oncogene 2003, 22:8619-8627.
18. Monteith G.R., McAndrew D., Faddy H.M., Roberts-Thomson S.J. Calcium and cancer: targeting Ca2+ transport. Nature Reviews. Cancer 2007, 7:519-530.
19. Bidaux G., Flourakis M., Thebault S., Zholos A., Beck B., Gkika D., Roudbaraki M., Bonnal J.L., Mauroy B., Shuba Y., Skryma R., Prevarskaya N. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function. The Journal of Clinical Investigation 2007, 117:1647-1657.
20. Thebault S., Lemonnier L., Bidaux G., Flourakis M., Bavencoffe A., Gordienko D., Roudbaraki M., Delcourt P., Panchin Y., Shuba Y., Skryma R., Prevarskaya N. Novel role of cold/menthol-sensitive transient receptor potential melastatine family member 8 (TRPM8) in the activation of store-operated channels in LNCaP human prostate cancer epithelial cells. The Journal of Biological Chemistry 2005, 280:39423-39435.
21. Xu X.Z., Moebius F., Gill D.L., Montell C. Regulation of melastatin, a TRP-related protein, through interaction with a cytoplasmic isoform. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:10692-10697.
22. Wisnoskey B.J., Sinkins W.G., Schilling W.P. Activation of vanilloid receptor type I in the endoplasmic reticulum fails to activate store-operated Ca2+ entry. The Biochemical Journal 2003, 372:517-528.
23. Xin H., Tanaka H., Yamaguchi M., Takemori S., Nakamura A., Kohama K. Vanilloid receptor expressed in the sarcoplasmic reticulum of rat skeletal muscle. Biochemical and Biophysical Research Communications 2005, 332:756-762.
24. Ambudkar I.S. TRPC1: a core component of store-operated calcium channels. Biochemical Society Transactions 2007, 35:96-100.
25. Liu X., Singh B.B., Ambudkar I.S. TRPC1 is required for functional store-operated Ca2+ channels. Role of acidic amino acid residues in the S5-S6 region. The Journal of Biological Chemistry 2003, 278:11337-11343.
26. Ong H.L., Cheng K.T., Liu X., Bandyopadhyay B.C., Paria B.C., Soboloff J., Pani B., Gwack Y., Srikanth S., Singh B.B., Gill D.L., Ambudkar I.S. Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx. Evidence for similarities in store-operated and calcium release-activated calcium channel components. The Journal of Biological Chemistry 2007, 282:9105-9116.
27. Li J., Sukumar P., Milligan C.J., Kumar B., Ma Z.Y., Munsch C.M., Jiang L.H., Porter K.E., Beech D.J. Interactions, functions, and independence of plasma membrane STIM1 and TRPC1 in vascular smooth muscle cells. Circulation Research 2008, 103:e97-e104.
28. Potier M., Gonzalez J.C., Motiani R.K., Abdullaev I.F., Bisaillon J.M., Singer H.A., Trebak M. Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2009, 23:2425-2437.
29. Dietrich A., Kalwa H., Storch U., Mederos y Schnitzler M., Salanova B., Pinkenburg O., Dubrovska G., Essin K., Gollasch M., Birnbaumer L., Gudermann T. Pressure-induced and store-operated cation influx in vascular smooth muscle cells is independent of TRPC1. Pflugers Archiv: European Journal of Physiology 2007, 455:465-477.
30. Zanou N., Shapovalov G., Louis M., Tajeddine N., Gallo C., Van Schoor M., Anguish I., Cao M.L., Schakman O., Dietrich A., Lebacq J., Ruegg U., Roulet E., Birnbaumer L., Gailly P. Role of TRPC1 channel in skeletal muscle function. American Journal of Physiology. Cell Physiology 2010, 298:C149-C162.
31. P. Ariano, S. Dalmazzo, G. Owsianik, B. Nilius, D. Lovisolo, TRPC channels are involved in calcium-dependent migration and proliferation in immortalized GnRH neurons, Cell Calcium (2011), in press, doi:10.1016/j.ceca.2011.03.007.
32. Fabian A., Fortmann T., Bulk E., Bomben V.C., Sontheimer H., Schwab A. Chemotaxis of MDCK-F cells toward fibroblast growth factor-2 depends on transient receptor potential canonical channel 1. Pflugers Archiv: European Journal of Physiology 2011, 461:295-306.
33. Fabian A., Fortmann T., Dieterich P., Riethmuller C., Schon P., Mally S., Nilius B., Schwab A. TRPC1 channels regulate directionality of migrating cells. Pflugers Archiv: European Journal of Physiology 2008, 457:475-484.
34. Marasa B.S., Rao J.N., Zou T., Liu L., Keledjian K.M., Zhang A.H., Xiao L., Chen J., Turner D.J., Wang J.Y. Induced TRPC1 expression sensitizes intestinal epithelial cells to apoptosis by inhibiting NF-kappaB activation through Ca2+ influx. The Biochemical Journal 2006, 397:77-87.
35. Thebault S., Flourakis M., Vanoverberghe K., Vandermoere F., Roudbaraki M., Lehen'kyi V., Slomianny C., Beck B., Mariot P., Bonnal J.L., Mauroy B., Shuba Y., Capiod T., Skryma R., Prevarskaya N. Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells. Cancer Research 2006, 66:2038-2047.
36. Wang Y., Yue D., Li K., Liu Y.L., Ren C.S., Wang P. The role of TRPC6 in HGF-induced cell proliferation of human prostate cancer DU145 and PC3 cells. Asian Journal of Andrology 2010, 12:841-852.
37. Feng S.L., Sun M.R., Li T.T., Xin Y., Xu C.Q., Sun Y.H. Activation of calcium-sensing receptor increases TRPC3 expression in rat cardiomyocytes. Biochemical and Biophysical Research Communications 2011, 406:278-284.
38. Ellis L.M., Hicklin D.J. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nature Reviews. Cancer 2008, 8:579-591.
39. Cheng H.W., James A.F., Foster R.R., Hancox J.C., Bates D.O. VEGF activates receptor-operated cation channels in human microvascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:1768-1776.
40. Ge R., Tai Y., Sun Y., Zhou K., Yang S., Cheng T., Zou Q., Shen F., Wang Y. Critical role of TRPC6 channels in VEGF-mediated angiogenesis. Cancer Letters 2009, 283:43-51.
41. Kwan H.Y., Huang Y., Yao X. TRP channels in endothelial function and dysfunction. Biochimica et Biophysica Acta 2007, 1772:907-914.
42. Bodding M., Flockerzi V. Ca2+ dependence of the Ca2+-selective TRPV6 channel. The Journal of Biological Chemistry 2004, 279:36546-36552.
43. Bodding M., Wissenbach U., Flockerzi V. The recombinant human TRPV6 channel functions as Ca2+ sensor in human embryonic kidney and rat basophilic leukemia cells. The Journal of Biological Chemistry 2002, 277:36656-36664.
44. Yue L., Peng J.B., Hediger M.A., Clapham D.E. CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature 2001, 410:705-709.
45. Peng J.B., Chen X.Z., Berger U.V., Vassilev P.M., Tsukaguchi H., Brown E.M., Hediger M.A. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. The Journal of Biological Chemistry 1999, 274:22739-22746.
46. Wissenbach U., Niemeyer B.A., Fixemer T., Schneidewind A., Trost C., Cavalie A., Reus K., Meese E., Bonkhoff H., Flockerzi V. Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. The Journal of Biological Chemistry 2001, 276:19461-19468.
47. Taparia S., Fleet J.C., Peng J.B., Wang X.D., Wood R.J. 1,25-Dihydroxyvitamin D and 25-hydroxyvitamin D-mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco-2 cells. European Journal of Nutrition 2006, 45:196-204.
48. Peng J.B., Zhuang L., Berger U.V., Adam R.M., Williams B.J., Brown E.M., Hediger M.A., Freeman M.R. CaT1 expression correlates with tumor grade in prostate cancer. Biochemical and Biophysical Research Communications 2001, 282:729-734.
49. Peng J.B., Chen X.Z., Berger U.V., Weremowicz S., Morton C.C., Vassilev P.M., Brown E.M., Hediger M.A. Human calcium transport protein CaT1. Biochemical and Biophysical Research Communications 2000, 278:326-332.
50. Bolanz K.A., Hediger M.A., Landowski C.P. The role of TRPV6 in breast carcinogenesis. Molecular Cancer Therapeutics 2008, 7:271-279.
51. Fixemer T., Wissenbach U., Flockerzi V., Bonkhoff H. Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 2003, 22:7858-7861.
52. Zhuang L., Peng J.B., Tou L., Takanaga H., Adam R.M., Hediger M.A., Freeman M.R. Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Laboratory Investigation; A Journal of Technical Methods and Pathology 2002, 82:1755-1764.
53. Wissenbach U., Niemeyer B., Himmerkus N., Fixemer T., Bonkhoff H., Flockerzi V. TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression. Biochemical and Biophysical Research Communications 2004, 322:1359-1363.
54. Bodding M., Fecher-Trost C., Flockerzi V. Store-operated Ca2+ current and TRPV6 channels in lymph node prostate cancer cells. The Journal of Biological Chemistry 2003, 278:50872-50879.
55. Vanden Abeele F., Roudbaraki M., Shuba Y., Skryma R., Prevarskaya N. Store-operated Ca2+ current in prostate cancer epithelial cells. Role of endogenous Ca2+ transporter type 1. The Journal of Biological Chemistry 2003, 278:15381-15389.
56. Lehen'kyi V., Flourakis M., Skryma R., Prevarskaya N. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene 2007, 26:7380-7385.
57. Schwarz E.C., Wissenbach U., Niemeyer B.A., Strauss B., Philipp S.E., Flockerzi V., Hoth M. TRPV6 potentiates calcium-dependent cell proliferation. Cell Calcium 2006, 39:163-173.
58. Kahr H., Schindl R., Fritsch R., Heinze B., Hofbauer M., Hack M.E., Mortelmaier M.A., Groschner K., Peng J.B., Takanaga H., Hediger M.A., Romanin C. CaT1 knock-down strategies fail to affect CRAC channels in mucosal-type mast cells. The Journal of Physiology 2004, 557:121-132.
59. Vanden Abeele F., Lemonnier L., Thebault S., Lepage G., Parys J.B., Shuba Y., Skryma R., Prevarskaya N. Two types of store-operated Ca2+ channels with different activation modes and molecular origin in LNCaP human prostate cancer epithelial cells. The Journal of Biological Chemistry 2004, 279:30326-30337.
60. Ghilardi J.R., Rohrich H., Lindsay T.H., Sevcik M.A., Schwei M.J., Kubota K., Halvorson K.G., Poblete J., Chaplan S.R., Dubin A.E., Carruthers N.I., Swanson D., Kuskowski M., Flores C.M., Julius D., Mantyh P.W. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2005, 25:3126-3131.
61. Menendez L., Juarez L., Garcia E., Garcia-Suarez O., Hidalgo A., Baamonde A. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neuroscience Letters 2006, 393:70-73.
62. Chow J., Norng M., Zhang J., Chai J. TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells - mechanisms behind a possible new " hot" cancer treatment. Biochimica et Biophysica Acta 2007, 1773:565-576.
63. Sappington R.M., Sidorova T., Long D.J., Calkins D.J. TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Investigative Ophthalmology & Visual Science 2009, 50:717-728.
64. Domotor A., Peidl Z., Vincze A., Hunyady B., Szolcsanyi J., Kereskay L., Szekeres G., Mozsik G. Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders. Inflammopharmacology 2005, 13:161-177.
65. Hartel M., di Mola F.F., Selvaggi F., Mascetta G., Wente M.N., Felix K., Giese N.A., Hinz U., Di Sebastiano P., Buchler M.W., Friess H. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut 2006, 55:519-528.
66. Lazzeri M., Vannucchi M.G., Spinelli M., Bizzoco E., Beneforti P., Turini D., Faussone-Pellegrini M.S. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder. European Urology 2005, 48:691-698.
67. Sanchez M.G., Sanchez A.M., Collado B., Malagarie-Cazenave S., Olea N., Carmena M.J., Prieto J.C., Diaz-Laviada I.I. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. European Journal of Pharmacology 2005, 515:20-27.
68. Duncan L.M., Deeds J., Hunter J., Shao J., Holmgren L.M., Woolf E.A., Tepper R.I., Shyjan A.W. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Research 1998, 58:1515-1520.
69. Deeds J., Cronin F., Duncan L.M. Patterns of melastatin mRNA expression in melanocytic tumors. Human Pathology 2000, 31:1346-1356.
70. Duncan L.M., Deeds J., Cronin F.E., Donovan M., Sober A.J., Kauffman M., McCarthy J.J. Melastatin expression and prognosis in cutaneous malignant melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2001, 19:568-576.
71. Fang D., Setaluri V. Expression and up-regulation of alternatively spliced transcripts of melastatin, a melanoma metastasis-related gene, in human melanoma cells. Biochemical and Biophysical Research Communications 2000, 279:53-61.
72. Bodding M. TRP proteins and cancer. Cellular Signalling 2007, 19:617-624.
73. Erickson L.A., Letts G.A., Shah S.M., Shackelton J.B., Duncan L.M. TRPM1 (melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc. 2009, 22:969-976.
74. Lis A., Wissenbach U., Philipp S.E. Transcriptional regulation and processing increase the functional variability of TRPM channels. Naunyn-Schmiedeberg's Archives of Pharmacology 2005, 371:315-324.
75. Miller A.J., Du J., Rowan S., Hershey C.L., Widlund H.R., Fisher D.E. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma. Cancer Research 2004, 64:509-516.
76. Zhiqi S., Soltani M.H., Bhat K.M., Sangha N., Fang D., Hunter J.J., Setaluri V. Human melastatin 1 (TRPM1) is regulated by MITF and produces multiple polypeptide isoforms in melanocytes and melanoma. Melanoma Research 2004, 14:509-516.
77. Hara Y., Wakamori M., Ishii M., Maeno E., Nishida M., Yoshida T., Yamada H., Shimizu S., Mori E., Kudoh J., Shimizu N., Kurose H., Okada Y., Imoto K., Mori Y. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Molecular Cell 2002, 9:163-173.
78. Zhang W., Chu X., Tong Q., Cheung J.Y., Conrad K., Masker K., Miller B.A. A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death. The Journal of Biological Chemistry 2003, 278:16222-16229.
79. Fonfria E., Marshall I.C., Benham C.D., Boyfield I., Brown J.D., Hill K., Hughes J.P., Skaper S.D., McNulty S. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. British Journal of Pharmacology 2004, 143:186-192.
80. McNulty S., Fonfria E. The role of TRPM channels in cell death. Pflugers Archiv: European Journal of Physiology 2005, 451:235-242.
81. Suguro M., Tagawa H., Kagami Y., Okamoto M., Ohshima K., Shiku H., Morishima Y., Nakamura S., Seto M. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature. Cancer Science 2006, 97:868-874.
82. Prawitt D., Enklaar T., Klemm G., Gartner B., Spangenberg C., Winterpacht A., Higgins M., Pelletier J., Zabel B. Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression. Human Molecular Genetics 2000, 9:203-216.
83. Chen H.C., Xie J., Zhang Z., Su L.T., Yue L., Runnels L.W. Blockade of TRPM7 channel activity and cell death by inhibitors of 5-lipoxygenase. PLoS One 2010, 5:e11161.
84. Aarts M., Iihara K., Wei W.L., Xiong Z.G., Arundine M., Cerwinski W., MacDonald J.F., Tymianski M. A key role for TRPM7 channels in anoxic neuronal death. Cell 2003, 115:863-877.
85. Sun H.S., Jackson M.F., Martin L.J., Jansen K., Teves L., Cui H., Kiyonaka S., Mori Y., Jones M., Forder J.P., Golde T.E., Orser B.A., Macdonald J.F., Tymianski M. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nature Neuroscience 2009, 12:1300-1307.
86. Guilbert A., Gautier M., Dhennin-Duthille I., Haren N., Sevestre H., Ouadid-Ahidouch H. Evidence that TRPM7 is required for breast cancer cell proliferation. American Journal of Physiology. Cell Physiology 2009, 297:C493-C502.
87. Voets T., Droogmans G., Wissenbach U., Janssens A., Flockerzi V., Nilius B. The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature 2004, 430:748-754.
88. McKemy D.D., Neuhausser W.M., Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 2002, 416:52-58.
89. Peier A.M., Moqrich A., Hergarden A.C., Reeve A.J., Andersson D.A., Story G.M., Earley T.J., Dragoni I., McIntyre P., Bevan S., Patapoutian A. A TRP channel that senses cold stimuli and menthol. Cell 2002, 108:705-715.
90. Tsavaler L., Shapero M.H., Morkowski S., Laus R. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Research 2001, 61:3760-3769.
91. Voets T., Owsianik G., Nilius B. Trpm8. Handbook of Experimental Pharmacology 2007, 329-344.
92. Bidaux G., Roudbaraki M., Merle C., Crepin A., Delcourt P., Slomianny C., Thebault S., Bonnal J.L., Benahmed M., Cabon F., Mauroy B., Prevarskaya N. Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocrine-related Cancer 2005, 12:367-382.
93. Prevarskaya N., Skryma R., Bidaux G., Flourakis M., Shuba Y. Ion channels in death and differentiation of prostate cancer cells. Cell Death and Differentiation 2007, 14:1295-1304.
94. Fuessel S., Sickert D., Meye A., Klenk U., Schmidt U., Schmitz M., Rost A.K., Weigle B., Kiessling A., Wirth M.P. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR. International Journal of Oncology 2003, 23:221-228.
95. Zhang L., Barritt G.J. Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. Cancer Research 2004, 64:8365-8373.
96. Henshall S.M., Afar D.E., Hiller J., Horvath L.G., Quinn D.I., Rasiah K.K., Gish K., Willhite D., Kench J.G., Gardiner-Garden M., Stricker P.D., Scher H.I., Grygiel J.J., Agus D.B., Mack D.H., Sutherland R.L. Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Research 2003, 63:4196-4203.
97. Berges R.R., Vukanovic J., Epstein J.I., CarMichel M., Cisek L., Johnson D.E., Veltri R.W., Walsh P.C., Isaacs J.T. Implication of cell kinetic changes during the progression of human prostatic cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1995, 1:473-480.
98. Kiessling A., Fussel S., Schmitz M., Stevanovic S., Meye A., Weigle B., Klenk U., Wirth M.P., Rieber E.P. Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8. The Prostate 2003, 56:270-279.
99. Tsuzuki K., Xing H., Ling J., Gu J.G. Menthol-induced Ca2+ release from presynaptic Ca2+ stores potentiates sensory synaptic transmission. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2004, 24:762-771.
100. Prevarskaya N., Zhang L., Barritt G. TRP channels in cancer. Biochimica et Biophysica Acta 2007, 1772:937-946.
101. Legrand G., Humez S., Slomianny C., Dewailly E., Vanden Abeele F., Mariot P., Wuytack F., Prevarskaya N. Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control. The Journal of Biological Chemistry 2001, 276:47608-47614.
102. Thebault S., Roudbaraki M., Sydorenko V., Shuba Y., Lemonnier L., Slomianny C., Dewailly E., Bonnal J.L., Mauroy B., Skryma R., Prevarskaya N. Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells. The Journal of Clinical Investigation 2003, 111:1691-1701.
103. Skryma R., Mariot P., Bourhis X.L., Coppenolle F.V., Shuba Y., Vanden Abeele F., Legrand G., Humez S., Boilly B., Prevarskaya N. Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis. The Journal of Physiology 2000, 527(Pt. 1):71-83.
104. Liu B., Qin F. Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2005, 25:1674-1681.
105. Rohacs T., Lopes C.M., Michailidis I., Logothetis D.E. PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nature Neuroscience 2005, 8:626-634.
106. Vanden Abeele F., Zholos A., Bidaux G., Shuba Y., Thebault S., Beck B., Flourakis M., Panchin Y., Skryma R., Prevarskaya N. Ca2+-independent phospholipase A2-dependent gating of TRPM8 by lysophospholipids. The Journal of Biological Chemistry 2006, 281:40174-40182.
107. Andersson D.A., Nash M., Bevan S. Modulation of the cold-activated channel TRPM8 by lysophospholipids and polyunsaturated fatty acids. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:3347-3355.
108. El Boustany C., Bidaux G., Enfissi A., Delcourt P., Prevarskaya N., Capiod T. Capacitative calcium entry and transient receptor potential canonical 6 expression control human hepatoma cell proliferation. Hepatology 2008, 47:2068-2077.